2022 UAB School of Medicine Disclosure Summary
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Alabama School of Medicine (UASOM) and Ophthalmic Anesthesia Society (OAS).
The UASOM is accredited by the ACCME to provide continuing medical education for physicians. The University of Alabama School of Medicine designates this live activity for a maximum of 15.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURES AND ACKNOWLEDGEMENTS
The University of Alabama School of Medicine (UAB) and the Division of Continuing Medical Education are committed to the provision of CME that is balanced, objective, evidence based and free from the control or influence of commercial interests. We strictly adhere to the Accreditation Council for Continuing Medical Education’s Essential Areas and Their Elements including the Standards for Commercial Support. Accordingly, all persons in a position to control the content of this educational activity have disclosed all relevant financial relationships and any conflicts of interest have been mitigated.
THEREFORE THE FOLLOWING DISCLOSURES ARE MADE
The following persons have disclosed that, related to their participation in this activity, neither they nor their families have any relevant financial relationships with any commercial interests:
- Yassine Daoud, MD
- Simon Hill, RN, BSN
- Howard Palte, MD
- George Dumas, MD
- Maggie Jeffries, MD
- Mark Phillips, MD
- Anna Gabriellan, MD
- Edward Kuwera, MD
- Vinodkumar Singh, MD
- Iosifina Giannarkikou, MD
- Elaine Liew, MD
- Pete Spitelle, MD
- Christina Giblin, MD
- Lindsey Nelson, MD
- Tina Tran, MD
- Randolf Harvey, CRNA, BSN
- Timmy Nguyen, MD
The following persons have disclosed the following relationships with commercial interests related to their
participation in this activity:
- Chris Bender, CRNA Consulting fee: Imprimis Pharmaceuticals Royalties: Imprimis Pharmaceuticals
- Jefferson Doyle, MD Patents: Erk Inhibitors for Aortic Aneurysm
- William Myers, MD Consulting fee: Leiters, Carl Zeiss Meditec
- Kanwal Nischal, MD Grants/research support: Essilor Ocumension
- Fatemeh Rajaii, MD Consulting fee: Horizon Therapeutics Stock/shareholder: Horizon Therapeutics
We gratefully acknowledge an unrestricted educational grant from Imprimis Pharmaceuticals.